Halozyme Therapeutics, Inc. (HALO)
62.33
-0.55
(-0.87%)
USD |
NASDAQ |
Dec 09, 15:00
Halozyme Therapeutics Total Liabilities (Quarterly): 1.717B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 77.64B |
| ANI Pharmaceuticals, Inc. | 902.34M |
| Bristol Myers Squibb Co. | 78.29B |
| Twist Bioscience Corp. | 168.90M |
| Aurinia Pharmaceuticals, Inc. | 161.76M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.221B |
| Shareholders Equity (Quarterly) | 503.92M |
| Debt to Equity Ratio | 2.998 |
| Current Ratio | 1.587 |
| Net Debt Paydown Yield | -0.02% |